Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 5 institutions in 2 countries.
Antonio GidaroDepartment of Biomedical and Clinical Sciences Luigi Sacco, Luigi Sacco Hospital, University of Milan, Via G.B. Grassi N° 74, 20157 Milan, Italy.ORCID 0000-0002-5379-1091
Alessandro Palmerio DelitalaDepartment of Medicine, Surgery and Pharmacy, University of Sassari, Viale San Pietro N° 8, 07100 Sassari, Italy.
Alessandra BerzuiniFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza, 28, 20122 Milan, Italy.
Mark J SoloskiDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
Pietro MancaTransfusion Center, Azienda Ospedaliero Universitaria, Piazza Università, N° 21, 07100 Sassari, Italy.
Dante CastroDepartment of Medicine, Surgery and Pharmacy, University of Sassari, Viale San Pietro N° 8, 07100 Sassari, Italy.
Emanuele SalviDepartment of Biomedical and Clinical Sciences Luigi Sacco, Luigi Sacco Hospital, University of Milan, Via G.B. Grassi N° 74, 20157 Milan, Italy.
Roberto ManettiDepartment of Medicine, Surgery and Pharmacy, University of Sassari, Viale San Pietro N° 8, 07100 Sassari, Italy.ORCID 0000-0001-7376-2303
Giorgio Lambertenghi DeliliersFondazione Mattarelli Largo della Crocetta, 2, 20122 Milan, Italy.
Roberto CastelliDepartment of Medicine, Surgery and Pharmacy, University of Sassari, Viale San Pietro N° 8, 07100 Sassari, Italy.ORCID 0000-0003-3976-7690
University of Sassari · ITUniversity of Milan · ITAzienda Ospedaliero Universitaria di Sassari · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITJohns Hopkins University · US
Funding
MJS was supported by grant 076855631 from the Fulbright U.S. Scholar Program/Fondazione Con Il Sud. 076855631The paper was funded by Progetto Fondazione di Sardegna year 2022-2023. year 2022-2023.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Ferric Carboxymaltose and Erythropoiesis-Stimulating Agent Treatment Reduces the Rate of Blood Transfusion in Refractory Anemia. · full record | OpenQuestion